Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcello Moccia

Showing results (71-80 of 221) with videos related to

Pageof 23
Sort By:
Scientific Reports|December 4, 2019
Associations between cognitive impairment at onset and disability accrual in young people with multiple sclerosisAntonio Carotenuto, Marcello Moccia, Teresa Costabile, et al.
Therapeutics and Clinical Risk Management|October 21, 2014
JC virus antibody index in natalizumab-treated patients: correlations with John Cunningham virus DNA and C-reactive protein levelRoberta Lanzillo, Raffaele Liuzzi, Luca Vallefuoco, et al.
Multiple Sclerosis and Related Disorders|November 27, 2022
The independent contribution of brain, spinal cord and gadolinium MRI in treatment decision in multiple sclerosis: A population-based retrospective studyGiulia Dallera, Giuseppina Affinito, Daniele Caliendo, et al.
Plos One|September 29, 2021
Interferon beta for the treatment of multiple sclerosis in the Campania Region of Italy: Merging the real-life to routinely collected healthcare dataMarcello Moccia, Giuseppina Affinito, Antonio Capacchione, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 22, 2017
Optical coherence tomography angiography retinal vascular network assessment in multiple sclerosisRoberta Lanzillo, Gilda Cennamo, Chiara Criscuolo, et al.
Multiple Sclerosis and Related Disorders|June 20, 2020
COVID-19 prevention and multiple sclerosis management: The SAFE pathway for the post-peakAntonio Buonomo, Vincenzo Brescia Morra, Emanuela Zappulo, et al.
Journal of the Neurological Sciences|March 25, 2014
How does smoking affect olfaction in Parkinson's disease?Marcello Moccia, Marina Picillo, Roberto Erro, et al.
Parkinsonism & Related Disorders|October 1, 2015
Speech discrimination is impaired in parkinsonian patients: Expanding the audiologic findings of Parkinson's diseaseCarmine Vitale, Vincenzo Marcelli, Teresa Abate, et al.
Multiple Sclerosis and Related Disorders|January 10, 2019
Therapeutic lag in reducing disability progression in relapsing-remitting multiple sclerosis: 8-year follow-up of two randomized add-on trials with atorvastatinRoberta Lanzillo, Marcello Moccia, Cinzia Valeria Russo, et al.
Acta Neurologica Scandinavica|October 3, 2015
Neuropsychological correlates of Pisa syndrome in patients with Parkinson's diseaseCarmine Vitale, Fabrizia Falco, Luigi Trojano, et al.
Pageof 23

Showing results (71-80 of 221) with videos related to

Sort By:
Pageof 23
Scientific Reports|December 4, 2019
Associations between cognitive impairment at onset and disability accrual in young people with multiple sclerosisAntonio Carotenuto, Marcello Moccia, Teresa Costabile, et al.
Therapeutics and Clinical Risk Management|October 21, 2014
JC virus antibody index in natalizumab-treated patients: correlations with John Cunningham virus DNA and C-reactive protein levelRoberta Lanzillo, Raffaele Liuzzi, Luca Vallefuoco, et al.
Multiple Sclerosis and Related Disorders|November 27, 2022
The independent contribution of brain, spinal cord and gadolinium MRI in treatment decision in multiple sclerosis: A population-based retrospective studyGiulia Dallera, Giuseppina Affinito, Daniele Caliendo, et al.
Plos One|September 29, 2021
Interferon beta for the treatment of multiple sclerosis in the Campania Region of Italy: Merging the real-life to routinely collected healthcare dataMarcello Moccia, Giuseppina Affinito, Antonio Capacchione, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 22, 2017
Optical coherence tomography angiography retinal vascular network assessment in multiple sclerosisRoberta Lanzillo, Gilda Cennamo, Chiara Criscuolo, et al.
Multiple Sclerosis and Related Disorders|June 20, 2020
COVID-19 prevention and multiple sclerosis management: The SAFE pathway for the post-peakAntonio Buonomo, Vincenzo Brescia Morra, Emanuela Zappulo, et al.
Journal of the Neurological Sciences|March 25, 2014
How does smoking affect olfaction in Parkinson's disease?Marcello Moccia, Marina Picillo, Roberto Erro, et al.
Parkinsonism & Related Disorders|October 1, 2015
Speech discrimination is impaired in parkinsonian patients: Expanding the audiologic findings of Parkinson's diseaseCarmine Vitale, Vincenzo Marcelli, Teresa Abate, et al.
Multiple Sclerosis and Related Disorders|January 10, 2019
Therapeutic lag in reducing disability progression in relapsing-remitting multiple sclerosis: 8-year follow-up of two randomized add-on trials with atorvastatinRoberta Lanzillo, Marcello Moccia, Cinzia Valeria Russo, et al.
Acta Neurologica Scandinavica|October 3, 2015
Neuropsychological correlates of Pisa syndrome in patients with Parkinson's diseaseCarmine Vitale, Fabrizia Falco, Luigi Trojano, et al.
Pageof 23